About Suma Genomics
Suma Genomics is a Healthcare company based in Manipal (India) founded in 2019. Genomic testing services for detecting genetic disorders are provided. Its Indian entity Suma Genomics Private Limited reported revenue of ₹30.8 Lakh. Suma Genomics offers products and services including Next Generation Sequencing, Sanger Sequencing, MLPA/TP-PCR, and Prenatal Diagnosis. Its focus areas include Life Sciences, Genomics, Genomics Services and Full Service.
Company details
Suma Genomics was founded in 2019 in Manipal, India, within the genomics sector. Sequencing data is utilized by the company to analyze mutations linked to diseases. Bioinformatics and genetic testing technologies are employed in these operations. Services focus on identifying genetic disorders through precise detection methods. The company operates primarily from its base in India, serving needs in genetic analysis.
- Headquarters Manipal, India
- SectorsHealthcare
- Website sumagenomics.com
- Legal Name Suma Genomics Private Limited
- Date of Incorporation 04 Jan, 2019
- Jurisdiction Manipal, Karnataka, India
- Annual Revenue₹30.8 Lakh
FY 2025 · +11% YoY
- Net Loss-₹3.5 Lakh
FY 2025 · -11% margin
- EBITDA-₹1.6 Lakh
FY 2025 · -5% margin
Associated legal entities of Suma Genomics
Suma Genomics operates through Suma Genomics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Suma Genomics Private Limited CIN U85100KA2019PTC120034 | Active | 04 Jan 2019 | Devanahalli, Karnataka | ₹0.3 Cr | 3 | View details |
Products & Services of Suma Genomics
Suma Genomics offers a comprehensive portfolio of products and services, including Next Generation Sequencing, Sanger Sequencing, MLPA/TP-PCR, and Prenatal Diagnosis.
Massively parallel technology for ultra-high throughput DNA analysis.
Method to detect point mutations in specific genes.
Technique using probes for targeted genomic region detection.
Service for diagnosing genetic conditions in fetuses.
Board of directors of Suma Genomics Private Limited (Suma Genomics)
Suma Genomics Private Limited is the primary company behind Suma Genomics. The board of Suma Genomics Private Limited currently have 3 directors; the longest-serving is Girisha Katta Mohan, appointed in 2019. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Girisha Katta Mohan DIN 08320941 | Director | 04 Jan 2019 | 7 yrs 10 mo | Suma Genomics Private Limited |
| Nagabushan Swamy Channaiah DIN 11247868 | Additional Director | 05 Nov 2025 | 1 yr | Suma Genomics Private Limited |
| Hunasagatta Gurappaiah Vijayamma DIN 11368172 | Additional Director | 05 Nov 2025 | 1 yr | Suma Genomics Private Limited |
Financials of Suma Genomics
Figures of Suma Genomics Private Limited, the primary company behind Suma Genomics, for FY 2025. Revenue was ₹30.8 Lakh (+11% year on year). Net loss was -₹3.5 Lakh (-11% margin). EBITDA was -₹1.6 Lakh (-5% margin). Revenue has grown at a compounded annual rate of -31% over three years and +18% over five years.
- ₹30.8 LakhRevenue · FY 2025 · +11% YoY
- -₹3.5 LakhNet loss · -11% margin
- -₹1.6 LakhEBITDA · -5% margin
- ₹10 LakhPaid-up capital
- -31%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Suma Genomics Private Limited are on its company page.
Detailed financial statements for Suma Genomics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Suma Genomics
Suma Genomics was founded in 2019.
Suma Genomics is headquartered in Manipal, India. It is registered at Manipal, Karnataka, India.
The primary company behind Suma Genomics, Suma Genomics Private Limited, reported revenue of ₹30.8 Lakh for FY 2025, up 11% year on year.
Suma Genomics was founded in 2019 in Manipal, India, within the genomics sector. Sequencing data is utilized by the company to analyze mutations linked to diseases. Bioinformatics and genetic testing technologies are employed in these operations. Services focus on identifying genetic disorders through precise detection methods. The company operates primarily from its base in India, serving needs in genetic analysis.
Suma Genomics offers Next Generation Sequencing, Sanger Sequencing, MLPA/TP-PCR, and Prenatal Diagnosis.
Suma Genomics operates through Suma Genomics Private Limited.
The legal entities of Suma Genomics currently have 3 directors, including Girisha Katta Mohan, Nagabushan Swamy Channaiah, Hunasagatta Gurappaiah Vijayamma.